Updated on 10 June 2013
The lawyer, Mr Manoharlal Sharma, pointed out in his lawsuit that Ranbaxy drugs that have been banned by the US are still being sold in the Indian market. "It is not a tale of cutting corners or lax manufacturing practices, but one of outright fraud, in which the company knowingly sold substandard drugs around the world, including in India, Africa and the US while working to deceive regulators," the PIL said.
Drug Controller General of India (DCGI), Dr G N Singh, said that his department is probing the issue. Ranbaxy meanwhile released a public statement assuring that all their products in both the Indian and globla markets are safe and effective.